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Abstract
Background: Approximately 150 million central venous catheters (CVC) are used each year in the United States. Catheter-
related bloodstream infections (CR-BSI) are one of the most important complications of the central venous catheters (CVCs).
Our objective was to compare the in-hospital mortality when the catheter is removed or not removed in patients with CR-
BSI.
Methods: We reviewed all episodes of CR-BSI that occurred in our intensive care unit (ICU) from January 2000 to December
2008. The standard method was defined as a patient with a CVC and at least one positive blood culture obtained from a
peripheral vein and a positive semi quantitative (.15 CFU) culture of a catheter segment from where the same organism
was isolated. The conservative method was defined as a patient with a CVC and at least one positive blood culture obtained
from a peripheral vein and one of the following: (1) differential time period of CVC culture versus peripheral culture
positivity of more than 2 hours, or (2) simultaneous quantitative blood culture with §5:1 ratio (CVC versus peripheral).
Results: 53 CR-BSI (37 diagnosed by the standard method and 16 by the conservative method) were diagnosed during the
study period. There was a no statistically significant difference in the in-hospital mortality for the standard versus the
conservative method (57% vs. 75%, p = 0.208) in ICU patients.
Conclusion: In our study there was a no statistically significant difference between the standard and conservative methods
in-hospital mortality.
Citation: Deliberato RO, Marra AR, Correˆa TD, Martino MDV, Correa L, et al. (2012) Catheter Related Bloodstream Infection (CR-BSI) in ICU Patients: Making the
Decision to Remove or Not to Remove the Central Venous Catheter. PLoS ONE 7(3): e32687. doi:10.1371/journal.pone.0032687
Editor: Charles C. Caldwell, University of Cincinnati, United States of America
Received November 2, 2011; Accepted January 29, 2012; Published March 5, 2012
Copyright:  2012 Deliberato et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rodrigo.deliberato@einstein.br
Introduction
Approximately 150 million central venous catheters (CVC) are
used each year in the United States. These catheters have
unquestionable benefits in current medical practice, but their
potential complications are also well known [1].
One of the main complications is catheter-related bloodstream
infection (CR-BSI). In the United States 150,000 new cases are
estimated to occur each year, of which approximately 80,000
occur in intensive care units (ICUs). Each new episode of CR-BSI
increases the risk of death by 12 to 25%, in addition to prolonging
hospitalization and increasing healthcare costs by $30,000 to
$50,000 [2,3,4].
In an attempt to reduce the rate of these infections, the Institute
for Health Care Improvement (IHI) and the Centers for Disease
Control and Prevention (CDC) have issued guidelines for the
prevention of CR-BSI, including: hand hygiene, maximum barrier
precautions for insertion, skin antisepsis with chlorhexidine,
careful choice of the insertion site and a proactive approach to
CVC removal [3,5].
The correct diagnosis of the infection is as important as these
recommendations. Clinical methods are known to have low
sensitivity and specificity and the current standard method for
diagnosis requires CVC removal and semi-quantitative culture of
the CVC tip together with a peripheral blood culture [3].
Unfortunately, more than 70% of the suspected CR-BSIs yield
negative blood culture results (no growth), meaning that the CVC
was unnecessarily removed [4,6,7,8].
Several conservative methods (not involving CVC removal)
have been investigated over recent years with the objective of
improving CR-BSI diagnostic accuracy for short-term catheters
and as well to avoid patient exposure to the risks of a new CVC
insertion [8].
Among the conservative methods described for diagnosing CR-
BSI are the paired quantitative blood cultures from the CVC and
peripheral vein and paired blood culture from the CVC and
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peripheral vein with differential time to positivity. Both methods
have been shown to be reliable, both for the diagnosis of CR-BSI
and for the identification of CVC colonization in patients with
short-term catheters [6,8].
So far, we are not aware of any study correlating suspected CR-
BSI management methods with clinical outcomes. Therefore, this
study was conducted with the objective of assessing the impact of
the standard (CVC removal) versus the conservative (no CVC
removal) methods on the clinical outcome (death) of ICU patients
with CR-BSI.
Methods
Setting
This study was conducted in the ICU of a tertiary care, private
hospital in Sa˜o Paulo, Brazil. This open model ICU is a 38-bed
medical-surgical unit where approximately 2,200 patients are
admitted each year.
Study Design
This was a retrospective study that reviewed all occurrences of
bloodstream infection (BSI) in the ICU over the 9 year period
January 1, 2000 to December 31, 2008.
These episodes were classified as catheter associated blood-
stream infection (CABSI) and catheter related bloodstream
infection (CR-BSI) [9]. Only the patients with CR-BSI were
included in our study.
Patients over 18 years old with CR-BSI were included in the
study and only the first episode of CR-BSI of each patient was
included. Exclusion criteria was pregnancy. No written informed
consent was required because it was a retrospective study. This
study was approved by our Institutional Review Board (IRB) –
The Ethical Committee of Hospital Israelita Albert Einstein.
The data collected included age, sex, admission date, date when
bacteremia was identified, outcome date, as well as the SIRS,
SAPS II, APACHE II, and SOFA scores [10,11,12,13] from two
days before the bacteremia until 14 days after the BSI event. Data
related to the CVC, such as type, site, indwelling time,
complications during insertion, the method used to diagnose
CR-BSI (standard versus conservative), as well as data on the ICU
admission diagnosis, prior antibiotic therapy, adjustments to
antimicrobial therapy in the first 24 hours, Charlson score [14]
and death (in-hospital) were also collected.
Definitions
The use of the standard method (removal of the central venous
catheter) for diagnosis of CR-BSI was defined as a patient with a
CVC and at least one positive blood culture obtained from a
peripheral vein and a positive semi-quantitative culture of a
catheter segment (.15 CFU) from which the same organism
(species and antimicrobial susceptibility) was isolated [7]. The use
of the conservative method (without removal of the central venous
catheter), to diagnose CR-BSI was defined as a patient with a
CVC and at least one positive blood culture obtained from a
peripheral vein plus one of the following: (1) differential time
period of CVC blood culture versus peripheral blood culture
positivity of more than 2 hours, (2) simultaneous quantitative
blood culture with a $5:1 ratio CFU (CVC to peripheral) [6].
Until December of 2003 the only way to make the CR-BSI
diagnosis in our department was using the standard method. After
that in 2004 the conservative methods started in our institution
and unless the patient was seriously ill (hypotension, hypoperfusion
or signs and symptoms of organ failure) this was the method of
choice in patients with suspected CR-BSI [2]. As soon as we made
the CR-BSI diagnosis (even using the conservative method), the
central venous catheter was removed as part of the treatment.
In our institution the internal jugular vein has been the first
choice for CVC placement since 2000. The catheters used were
ArrowsH 7 french - 20 cm, triple lumen and double lumen and
ArrowsH 12 french triple lumen - 20 cm (dialysis catheter). All
procedures were done using the sterile techniques recommend by
CDC (hand hygiene, skin antisepsis, aseptic technique, specific
catheter site dressings regimens and since April 2007 a daily
review of all lines with prompt removal of unnecessary lines) [3].
The clinical condition of each patient during the catheter-
related bloodstream infection was assessed daily and rated as
SIRS, sepsis, severe sepsis or septic shock using criteria previously
published by the American College of Chest Physicians/Society of
Critical Care Medicine (ACCP/SCCM) [10]. Systemic inflam-
matory response syndrome (SIRS) was defined by the presence of
two or more of the following: (1) temperature $38.3uC or #36uC,
(2) respiratory rate w20 breaths per minute or a PaCO2
,32 mmHg, (3) heart rate .90 beats per minute or (4) white
blood cell count .126103/mL or ,46103/mL or the presence of
more than 10% immature neutrophils [10].
Sepsis was defined as SIRS associated with at least one positive
blood culture. Sepsis associated with organ dysfunction, hypoten-
sion or systemic manifestations of hypoperfusion constituted severe
sepsis. Septic shock was defined as sepsis associated with
hypotension unresponsive to intravenous fluid challenge or
requiring a vasopressor agent [10].
The presence of organ system failure was assessed using the
criteria described by Fagon [15]. Adequate empiric antimicrobial
treatment was defined as antibiotic therapy administered within
24 hours after blood culture samples were obtained which the
microorganism was susceptible [16].
The primary endpoint was overall in-hospital mortality and the
secondary endpoints were ICU mortality, mortality in the
conservative method group during the first 24 hours and after
24 hours while the CVC was kept in place.
Microbiological methods
Standard method. The catheter tip culture was performed
using the Maki method, in which a 5 cm segment of the catheter
tip was rolled across a blood agar plate. The plate was then
incubated at 37uC for 24 hours. Results were reported for growth
equal to or exceeding 15 CFU/mL.
For the peripheral blood culture, 20 mL of blood were collected
from a peripheral site and inoculated in BACTECTM Plus
Aerobic/F Medium and BACTECTM Plus Anaerobic/F Medium
bottles. The bottles were then incubated in the BD BACTECTM
9240 System for up to 5 days.
Conservative method. Two methods were used: paired
blood cultures with differential time to positivity and number of
colonies count.
For this purpose up to 20 mL of blood were collected from a
peripheral site and the same amount of blood was drawn from the
central venous catheter.
The same amount of blood was inoculated on the BACTECTM-
Plus Aerobic/F Medium and HEMOBAC Trifa´sicoTM (PROBAC
do Brasil) media. The BACTECTMPlus Aerobic/F Medium bottle
followed the same routine previously described; the HEMOBAC
Trifa´sicoTM system consists of a liquid phase coupled with a dip
slide with chocolate agar, MacConkey agar, and Sabouraud agar,
where colonies can be counted once there is bacterial growth.
CR-BSI: The Impact of Different Diagnostic Methods
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Statistical analysis
For continuous variables, mean values were compared using
two-sample t-tests for independent samples. For continuous
variables, median values were compared using the Mann-Whitney
test. Differences in proportions were compared using a chi-squared
test or Fisher s exact test when appropriate. Values are reported as
mean 6 SD. All significance tests are two-tailed. Variables
significant for predicting mortality in univariate analysis were
entered into a logistic regression model when p-value,0.1. When
colinearity was identified between two variables, the one with the
greatest clinical relevance associated with mortality was included
in the multivariate analysis. The association of independent
variables was expressed as odds with 95% confidence intervals.
Alpha was set at 0.05. All statistical analyses were done using the
Statistical Package for the Social Sciences software (SPSS,
Chicago, IL, U.S.A.).
Results
Study population and patient characteristics
During the study period, a total of 247 bloodstream infections
occurred in our ICU. Of those 192 were classified as catheter
associated bloodstream infection and 55 were catheter-related
bloodstream infections.
Two patients (of those 55 with CR-BSI) were excluded because
they were transferred to other hospitals, so 53 were included in this
study.
Patients included in this study had a mean age of 64619.29
years. Fifty-three percent were male. At the onset of bacteremia,
the APACHE II mean value 6 standard deviation was
15.4364.52. At ICU admission, the main diagnoses were severe
sepsis (28%), respiratory failure (20%), post-operative (17%), other
shock states (13%), coronary heart disease (10%), and neurologic
disorders (10%) and acute renal failure (2%).
The main risk procedures before bacteremia were: mechanical
ventilation (75%), use of vasoactive drugs (55%), parenteral
nutrition (40%), hemodialysis (40%), and blood transfusions
(17%). Concerning the CVC characteristics, 70% were double-
lumen catheters, 26% hemodialysis catheter and 93% were
inserted into the anterior internal jugular vein with an indwelling
time (mean 6 standard deviation) of 16.3268.56 days. Of the 53
catheter-related bloodstream infections recorded in this study, 37
(69.8%) were diagnosed using the standard method (catheter
removal). Eighty five percent of the patients had received
antibiotic therapy over the 15-day period preceding bacteremia
[Table 1]. For all cases in our conservative group the diagnosis
was performed by differential time to positivity.
Microbiological features
Of the 53 cases of CR-BSI, 23 (43.4%) were due to gram-
negative bacilli, 19 (35.9%) were due to fungi and 11 (20.7%) were
caused by gram-positive cocci.
Of the gram-negative bacilli (43% Acinetobacter baumannii, 13%
Pseudomonas aeruginosa, 13% Klebsiella pneumoniae, 13% Enterobacter
spp and 18% other species); 35% were resistant to ciprofloxacin
and ceftazidime and sensitive to imipenem, 30% were resistant to
imipenem, ciprofloxacin and cefazidime, and 35% were suscep-
tible to ciprofloxacin, ceftazidime and imipenem.
Of all fungal infections, 42% by Candida albicans (all susceptible
to fluconazole), and the remainder were caused by non-albicans
species.
Of the gram-positive cocci, 54% were coagulase-negative
staphylococci, 10% were methicillin-susceptible Staphylococcus aureus
(MSSA), and 36% were Enterococcus faecalis (all sensitive to
vancomycin). There were no cases of methicillin-resistant
Staphylococcus aureus (MRSA).
Table 2 describes the microbiologic findings according to the
diagnostic method.
Outcomes
The analysis showed that 33 (62.2%) of the 53 patients died
during hospitalization, 21 (63.6%) in the standard method group
and 12 (36.4%) in the conservative method group. Of the 29
deaths occurring in the ICU, 17 (58.6%) were from the
conservative method group and 12 (41.3%) from the standard
method group. All 53(100%) patients had received antimicrobial
therapy based on the peripheral and CVC blood cultures, and 22
patients (41.5%) had their antibiotic regimen adjusted within the
first 24 hours. There was no difference in in-hospital mortality
between the groups (57% vs. 75% for standard vs. conservative,
p = 0.208) or for other risk factors assessed (age, sex, parenteral
nutrition, blood transfusion, indwelling bladder catheter, coagu-
lation disorder, prior antibiotic therapy vasoactive drugs, mechan-
ical ventilation, acute renal failure, dialysis, death in the ICU,
SAPS II, SOFA and APACHE II at admission and at the onset of
bacteremia, presence of septic shock, length of hospital stay before
bacteremia, Charlson .3, cvc indwelling time) [Table 1].
Concerning secondary endpoints, the mortality rate in the first
24 hours was the same in the standard method group and in the
conservative method group, 56%. However, when the standard
method was compared to the conservative method after the CVC
had been in place for 24 hours, different mortality rates were
observed 56% versus 100%, respectively. Of the 16 cases of CR-
BSI diagnosed using the conservative method, in 9 (56%) the
catheter was removed within 24 hours maximum, in 4 (25%) it
was removed within 48 hours and in 3 (18.9%) it was removed
after 72 hours.
According to the univariate analysis, the specific variables such
as age, renal dysfunction, hematological dysfunction, APACHE II
at the onset of bacteremia, and SAPS II at the onset of bacteremia
were the main risk factors associated with death. Based on multiple
logistic regression analysis, the independent predictor for death
was renal dysfunction (OR 5.5; CI 1.3–22.4) [Table 3].
Discussion
Our study showed no difference in mortality rates of patients
with CR-BSI when the two methods of diagnosis are compared –
standard vs. conservative (57% vs. 75%, p= 0.208), but there is a
difference in mortality when the conventional method is compared
to the conservative method in cases where the CVC is kept in
place for more than 24 hours (56% vs. 100%, respectively).
The conservative method for the diagnosis of CR-BSI has been
reported as reliable by Bouza et al [6] in a prospective study
comparing techniques that keep the CVC in place during the
diagnostic investigation of CR-BSI in ICU patients with short-
term catheters. The search for conservative methods to diagnose
CR-BSI in ICU patients is justified, since this is one of the major
nosocomial infections. Prior studies have shown that approxi-
mately 70% of the CVCs removed for diagnostic purposes were
not causal factors of infection [2].
In a metanalysis by Safdar et al eight different methods used to
diagnose CR-BSI were assessed; the authors showed that the
paired quantitative blood culture (conservative method) was the
most accurate test, with a sensitivity of 0.87 [95% CI, 0.83–0.91]
and a specificity of 0.98 [95% CI, 0.97–0.99] [8]. However, due to
its cost and complexity, this method is not yet routinely used. On
the other hand, the conservative method based on differential time
CR-BSI: The Impact of Different Diagnostic Methods
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to positivity was shown by Blot et al. to have 91% specificity and
94% sensitivity, with the advantage that many labs currently use
automated continuous blood culture monitoring, which makes this
method easy to perform and less expensive than the paired
quantitative culture [17]. For all cases in our conservative group
the diagnosis was performed by differential time to positivity.
The different mortality rates observed in our study and in the
US SCOPE [18] (Surveillance and Control of Pathogens of
Epidemiologic Importance) prospective analysis, 62% vs 27%,
may be explained by the fact that the infections recorded in the US
SCOPE study occurred both in ICU and non-ICU patients,
whereas in our study all the infections occurred in ICU patients,
who suffer from more complex and severe conditions. Another
explanation is provided by the microbiologic analyses, since our
gram-negative bacilli showed higher rates of resistance to
ciprofloxacin, ceftazidime and imipenem and because in our
series Acinetobacter baumannii was the most frequent gram-negative
bacillus. A recent study [19] performed in our ICU to decrease
Table 1. Characteristics of the patients with CR-BSI.
Standard method
N=37
Conservative method
N=16 p-value OR 95% CI
Demographic data
Age, mean 6 SD 66.83620.10 59.31616.6 0.2
Male gender 17 (45%) 11 (68%) 0.127 0.39 (0.11–1.33)
Parenteral nutrition 13 (35%) 08 (50%) 0.31 1.85 (0.56–6.07)
Indwelling bladder catheter 32 (86%) 14 (88%) 0.92 1.09 (0.19–6.33)
Vasoactive drug 22 (59%) 07 (44%) 0.292 0.53 (0.16–1.74)
Mechanical ventilation 31 (84%) 09 (56%) 0.032 0.25 (0.07–0.93)
Acute renal failure 23 (62%) 10 (62%) 0.981 1.01 (0.30–3.40)
Coagulation disorder 04 (11%) 04 (25%) 0.151 3 (0.64–14.06)
Dialysis 13 (35%) 08 (50%) 0.31 1.85 (0.56–6.07)
Prior antibiotic therapy 32 (86%) 13 (81%) 0.625 0.68 (0.14–3.25)
Adequate treatment in 1st 24 hours 15 (40%) 07 (44%) 0.828 1.14 (0.35–3.73)
Lenght of hospital stay before
bacteremia (days) median (range)
25 (3–245) 24.5 (9–143) 0.69
Blood transfusion 12 (32%) 05 (31%) 0.933 0.95 (0.27–3.34)
Septic shock 26 (70%) 12 (75%) 0.726 1.27 (0.33–4.81)
Measurement scores
APACHE II at admission, mean 6 SD 12.1665.29 11.8867.81 0.89
SAPS II at admission, mean 6 SD 36.03612.52 29.50613.23 0.1
SOFA at admission, mean 6 SD 3.8164.36 03.6963.38 0.92
APACHE II bacteremia, mean 6 SD 15.4364.62 15.4464.43 0.99
SAPS II bacteremia, mean 6 SD 43.05612.64 38.06612.91 0.2
SOFA bacteremia, mean 6 SD 06.97604.41 07.06603.43 0.94
Charlson .3 3.262.6 3.662.5 0.59 20.41 (21.96–1.14)
CVC characteristics
CVC insertion site:
Anterior jugular vein 33 (89.2%) 16 (100%)
Subclavian vein 2 (5.4%) -
Femoral vein 1 (2.7%) -
External jugular vein 1 (2.7%) -
Type of CVC:
Double lumen 29 (78.4%) 9 (56.3%)
Dialysis catheter 1 (2.7%) -
Triple lumen 7 (18.2%) 7 (43.8%)
CVC indwelling time (days), mean 6 SD 1769.2 14.866.8 0.35 2.16 (22.43–6.75)
Outcome
ICU mortality 17 (46%) 12 (75%) 0.051 3.52 (0.96–12.99)
In-hospital mortality 21 (57%) 12 (75%) 0.208 2.29 (0.62–8.43)
CVC= central venous catheter; SAPS II = simplified acute physiology score; SOFA= Sepsis-related Organ Failure Assessment; APACHE II = Acute Physiology and Chronic
Health disease Classification System II, Charlson = comorbidity index.
doi:10.1371/journal.pone.0032687.t001
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mortality in septic shock and severe sepsis by applying a sepsis
bundle, showed that the implementation of a rapid response team
contributed to decreasing our mortality rates from 52% in 2005 to
16% in 2009, justifying our higher mortality rate compared with
other studies [20] [21].
Another important difference was the rate of fungal infections,
36% vs. 7.6% in the US SCOPE project. Concerning gram-
positive cocci, our infections were mostly caused by coagulase-
negative staphylococci (54%) vs 58.9% in SCOPE.
Concerning Staphylococcus aureus, we had no infection caused by
methicillin-resistant staphylococcus (MRSA) vs 30.7% of MRSA
in SCOPE; and we had no vancomycin-resistant enterococcus vs
7.5% in SCOPE.
On other hand a recent multicenter Brazilian study showed that
in Brazil our epidemiology is different from the typical
epidemiology of ICU CR-BSI’s. More than 50% of the all
nosocomial bloodstream infections in this study were due to gram
negative bacilli [22]. The Brazilian SCOPE study also discloses a
pattern of BSI in Brazilian hospitals, considerably different from
the American experience. A very high proportion of aerobic gram-
negative bacteria, very high rates of resistance to carbapenems by
non-fermentative gram-negative bacteria, higher mortality rates
and a shift to non-albicans species of Candida were noted, and such
findings may help Brazilian hospitals to develop their own
guidelines for the treatment of BSI infections [22].
One of the major controversies, at present is about the best day
for the measurement of severity scores (e.g. APACHE II);
depending on the day, this may be a confounding factor when
analyzing results in patients with infections. Thom et al [23] have
shown in a retrospective study that time-adjusted hospital
mortality correlates with the day chosen for the measurement of
severity scores in patients with gram-negative bloodstream
infections and the day of onset of bacteremia seems to be the
best choice for these measurements. The same was observed in this
study, there was a statistically significant difference between
survivors and non-survivors from CRBSI concerning APACHE II
Table 2. Microbiological features by diagnostic method.
Conservative method
16 cases
Standard method
37 cases
Gram negative bacilli 6 (100%) 17 (100%)
Acinetobacter baumannii 2 (33.3%) 8 (47%)
Burkhloderia cepacia 1 (16.7%) 1 (5.9%)
Pseudomonas aeruginosa 1 (16.7%) 1 (5.9%)
Proteus mirabilis - 1 (5.9%)
Klebsiella pneumoniae - 2 (11.8%)
Stenotrophomonas maltophila - 2 (11.8%)
Enterobacter aerogenes - 2 (11.8%)
E. coli 1 (16.7%) -
Enterobacter clocae 1 (16.7%) -
Gram positive cocci 3 (100%) 7 (100%)
Enterococcus faecalis 1 (33.3%) 2 (28.6%)
Staphylococcus aureus - 1 (14.3%)
Staphylococcus epidermidis 1 (33.3%) 4 (57.1%)
Staphylococcus simulans 1 (33.3%) -
Fungi 7 (100%) 13 (100%)
Candida albicans 3 (42.9%) 6 (46.2%)
Candida parapsilosis 1 (14.3%) 5 (38.5%)
Candida glabrata - 1 (7.7%)
Candida krusei 2 (28.6%) -
Candida tropicalis 1 (14.3%) -
Saccharomyces cerevisiae - 1 (7.7%)
doi:10.1371/journal.pone.0032687.t002
Table 3. Risk factors for in-hospital mortality.
Non-survivors
N=33
Survivors
N=20 p-value
Univariate analysis
OR (95% CI)
Multivariate analysis
OR (95% CI)
Mean age 6 SD 69.55618.22 56.35618.58 0.016 1.03 (0.99–1.07)
Male gender 19 (57%) 9 (45%) 0.374 0.60 (0.2–1.84)
Respiratory dysfunction 26 (78%) 13 (65%) 0.471 1.6 (0.45–5.66)
Cardiovascular dysfunction 22 (66%) 8 (40%) 0.58 3 (0.95–9.48)
Renal dysfunction 27 (82%) 9 (45%) 0.005 5.5 (1.58–19.17) 5.5 (1.3–22.4)
Hematologic dysfunction 23 (70%) 4 (20%) ,0.001 9.2 (2.45–34.56)
Liver dysfunction 10 (30%) 2 (10%) 0.87 3.9 (0.76–20.15)
Conservative method 12 (36%) 4 (20%) 0.208 2.28 (0.62–8.43)
Adequate antimicrob ther 1st 24 h 12 (36%) 10 (50%) 0.329 0.57 (0.18–1.76)
Septic shock 28 (85%) 10 (50%) 0.006 5.6 (1.54–20.42)
Charlson .3 19 (57%) 7 (35%) 0.854 1.1 (0.36–3.40)
APACHEII bacteremia, mean 6 SD 16.7064.09 13.3564.51 0.01 1.1 (0.93–1.33)
SAPS II bacteremia, mean 6 SD 44.30611.51 37613.83 0.04 1.0 (0.95–1.07)
SOFA bacteremia, mean 6 SD 7.7063.91 5.8564.27 0.120
Prior ICU admission 23 (69%) 10 (50%) 0.152 2.3 (0.73–7.25)
CVC= central venous catheter; SAPS II = simplified acute physiology score; SOFA= Sepsis-related Organ Failure Assessment; APACHE II = Acute Physiology and Chronic
Health disease Classification System II, Charlson = comorbidity index.
doi:10.1371/journal.pone.0032687.t003
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and SAPSII scores measured on the day of onset of bacteremia (in
univariate analysis).
Our study was not an interventional study but an observational
study. We included only patients with CRBSI and our intention in
this study was to alert ICU doctors regarding the decision to keep
the catheter in place if there was a rapid time to positivity in blood
cultures. For this purpose there is a need for very good
communication between microlab and ICU doctor for a quick
notification regarding blood culture results so they can remove the
catheter as soon as they have the results.
To our knowledge, our study is the first assess the difference in
outcome between ICU patients with CR-BSI diagnosed by
standard versus conservative methods.
Strengths and limitations
The main limitations of our study were that it was a
retrospective study, conducted at a single center, on a small
sample of patients. Although there was no difference in mortality
rates, this small number of cases could lead to a type II error.
However, despite these limitations, the study included a highly
selective sample of patients with CR-BSI, and that 75% vs. 57%
may be clinically relevant. Of the 16 cases of CR-BSI diagnosed
using the conservative method, there was 100% of mortality when
the CVC was kept in place for more than 24 hs. Thus we did not
feel that the method of diagnosis is only a marker of sicker patients.
Also we are not sure if a power analysis is important considering
the context.
Conclusions
In case of CR-BSI it can be expected that prompt catheter
removal will result in shorter duration of BSI and improved
outcomes [24,25]. In our study there was a no statistically
significant difference between the standard and conservative
methods in-hospital mortality but there was a trend toward higher
mortality rates among patients with CR-BSI diagnosed by the
conservative method when the CVC was kept in place for more
than 24 h. Further studies should be conducted to confirm this
hypothesis.
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